PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.580.04 (-0.71%)
5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.08%
Positive revenue growth while UPM.HE is negative. John Neff might see a notable competitive edge here.
120.47%
Positive gross profit growth while UPM.HE is negative. John Neff would see a clear operational edge over the competitor.
26.84%
EBIT growth similar to UPM.HE's 28.76%. Walter Schloss might infer both firms share similar operational efficiencies.
26.84%
Operating income growth similar to UPM.HE's 28.76%. Walter Schloss would assume both share comparable operational structures.
28.03%
Net income growth comparable to UPM.HE's 26.75%. Walter Schloss might see both following similar market or cost trajectories.
25.00%
EPS growth similar to UPM.HE's 26.09%. Walter Schloss would assume both have parallel share structures and profit trends.
25.00%
Similar diluted EPS growth to UPM.HE's 26.09%. Walter Schloss might see standard sector or cyclical influences on both firms.
0.58%
Share count expansion well above UPM.HE's 0.00%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.58%
Diluted share change of 0.58% while UPM.HE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-71.54%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-74.46%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-27.12%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
2.43%
5Y revenue/share CAGR above 1.5x UPM.HE's 0.19%. David Dodd would look for consistent product or market expansions fueling outperformance.
-15.16%
Negative 3Y CAGR while UPM.HE stands at 1.08%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
497.93%
10Y OCF/share CAGR above 1.5x UPM.HE's 299.82%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-23.94%
Negative 5Y OCF/share CAGR while UPM.HE is at 99.26%. Joel Greenblatt would question the firm’s operational model or cost structure.
-15.81%
Negative 3Y OCF/share CAGR while UPM.HE stands at 92.66%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
143.23%
Net income/share CAGR at 75-90% of UPM.HE's 190.22%. Bill Ackman would press for strategic moves to boost long-term earnings.
650.00%
5Y net income/share CAGR 1.25-1.5x UPM.HE's 546.63%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
66.67%
3Y net income/share CAGR 50-75% of UPM.HE's 98.78%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
52.10%
5Y equity/share CAGR above 1.5x UPM.HE's 17.28%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
10.56%
3Y equity/share CAGR at 50-75% of UPM.HE's 15.06%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while UPM.HE stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
18.92%
AR growth well above UPM.HE's 29.85%. Michael Burry fears inflated revenue or higher default risk in the near future.
3.95%
Inventory growth well above UPM.HE's 6.11%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
3.61%
Positive asset growth while UPM.HE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-2.92%
We have a declining book value while UPM.HE shows 3.62%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
7.18%
We have some new debt while UPM.HE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-3.68%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.